
 [
{
"symbol" : "524689",
"exchange" : "BOM",
"id": "726547",
"t" : "524689",
"e" : "BOM",
"name" : "Parenteral Drugs (India) Ltd."
, "f_reuters_url" : "http:\u002F\u002Fstocks.us.reuters.com\u002Fstocks\u002Fratios.asp?rpc=66\u0026symbol=",
"f_recent_quarter_date" : "",
"f_annual_date" : "",
"f_ttm_date" : "",
"financials" :
[{
"f_type" : "Income\u0026nbsp\u003BStatement"
,"url" : "http:www.google.comfinance?fstype=ii&q=BOM:524689"
,"f_figures" :
[
]
},
{
"f_type" : "Balance\u0026nbsp\u003BSheet"
,"url" : "http:www.google.comfinance?fstype=bi&q=BOM:524689"
,"f_figures" :
[
]
},
{
"f_type" : "Cash\u0026nbsp\u003BFlow"
,"url" : "http:www.google.comfinance?fstype=ci&q=BOM:524689"
,"f_figures" :
[
]
}],
"kr_recent_quarter_date" : "Q3 (Sep \u002717)",
"kr_annual_date" : "2017",
"kr_ttm_date" : "TTM",
"keyratios" :
[
{
"title" : "Net profit margin",
"recent_quarter" : "-40.29%",
"annual" : "-50.15%",
"ttm" : "-56.64%"
},
{
"title" : "Operating margin",
"recent_quarter" : "-14.55%",
"annual" : "-18.51%",
"ttm" : "-24.12%"
},
{
"title" : "EBITD margin",
"recent_quarter" : "",
"annual" : "-7.63%",
"ttm" : "-13.23%"
},
{
"title" : "Return on average assets",
"recent_quarter" : "",
"annual" : "-11.05%",
"ttm" : "-14.66%"
},
{
"title" : "Return on average equity",
"recent_quarter" : "",
"annual" : "-43.01%",
"ttm" : ""
}
]
, "c" : "0.00",
"l" : "18.75",
"cp" : "0.00",
"ccol" : "chb",
"op" : "",
"hi" : "",
"lo" : "",
"vo" : "0.00",
"avvo" : "",
"hi52" : "32.00",
"lo52" : "16.50",
"mc" : "559.06M",
"pe" : "",
"fwpe" : "",
"beta" : "",
"eps" : "-43.66",
"dy" : "",
"ldiv" : "",
"shares" : "29.82M",
"instown" : "",
"eo":""
, "related" : [
{
"id" : "726547",
"name" : "Parenteral Drugs (India) Ltd.",
"t" : "524689",
"e" : "BOM",
"l" : "18.75",
"c" : "0.00",
"mc" : "559.06M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "13439600",
"name" : "Ahlcon Parenterals India Ltd",
"t" : "524448",
"e" : "BOM",
"l" : "0.00",
"c" : "",
"mc" : "",
"cp" : "",
"ccol" : ""
}
,
{
"id" : "133889985495148",
"name" : "Denis Chem Lab Ltd",
"t" : "537536",
"e" : "BOM",
"l" : "96.00",
"c" : "-0.10",
"mc" : "1.33B",
"cp" : "-0.10",
"ccol" : "chr"
}
,
{
"id" : "3033292",
"name" : "Hiran Orgochem Ltd",
"t" : "506170",
"e" : "BOM",
"l" : "0.48",
"c" : "0.00",
"mc" : "46.10M",
"cp" : "0.00",
"ccol" : "chb"
}
,
{
"id" : "14272879",
"name" : "Granules India Ltd",
"t" : "GRANULES",
"e" : "NSE",
"l" : "119.80",
"c" : "+2.45",
"mc" : "30.43B",
"cp" : "2.09",
"ccol" : "chg"
}
,
{
"id" : "4349663",
"name" : "Everest Organics Ltd",
"t" : "524790",
"e" : "BOM",
"l" : "139.95",
"c" : "+0.20",
"mc" : "1.12B",
"cp" : "0.14",
"ccol" : "chg"
}
,
{
"id" : "656764725561489",
"name" : "Lasa Supergenerics Ltd",
"t" : "LASA",
"e" : "NSE",
"l" : "121.40",
"c" : "-6.35",
"mc" : "2.78B",
"cp" : "-4.97",
"ccol" : "chr"
}
,
{
"id" : "16546949",
"name" : "Lincoln Pharmaceuticals Ltd",
"t" : "531633",
"e" : "BOM",
"l" : "239.25",
"c" : "+9.05",
"mc" : "4.77B",
"cp" : "3.93",
"ccol" : "chg"
}
,
{
"id" : "7268066",
"name" : "Auro Laboratories Ltd",
"t" : "530233",
"e" : "BOM",
"l" : "99.50",
"c" : "+0.95",
"mc" : "622.66M",
"cp" : "0.96",
"ccol" : "chg"
}
,
{
"id" : "5394531",
"name" : "Neuland Laboratories Ltd.",
"t" : "NEULANDLAB",
"e" : "NSE",
"l" : "707.35",
"c" : "+0.70",
"mc" : "6.28B",
"cp" : "0.10",
"ccol" : "chg"
}
,
{
"id" : "3900000",
"name" : "Smruthi Organics Ltd",
"t" : "540686",
"e" : "BOM",
"l" : "111.70",
"c" : "-2.80",
"mc" : "426.18M",
"cp" : "-2.45",
"ccol" : "chr"
}
]
, "summary" : [{
"address": "Shree Ganesh Chambers Navlakha Crossing,, A. B. Road, INDORE, 452001, India",
"phone": "+91-731-6652001",
"fax": "+91-731-2401052",
"url": "http:\u002F\u002Fwww.pdindia.com",
"overview" : "Parenteral Drugs (India) Limited is a healthcare company. The Company is engaged in the manufacturing of allopathic pharmaceutical preparations. The Company also manufactures intravenous (IV) Fluids. It offers products in various categories, including IV fluids, oncology, anesthesia and exports. Its IV Fluids include Carbohydrated and Electrolytes, such as Dextrose IP 25%, Ringer Lactate IP, and Multiple Eletrolytes and Dextrose Injection IP Type I\u003B Diuretics, such as Mannitol 10%, 20%\u003B Dialysis and Irrigation Solution, such as Peritoneal Dialysis Solution with 1.7% Dextrose\u003B Anti-infective and Anti-fungal, such as Ciprofloxacin 200mg, and Others, such as Tamolgan (Paracetamol 1000mg). Its Oncology product mix includes 5 FU-PAR, BLEOPAR, BOTEPAR and BAZIPAR. Its Anesthesia product mix includes Sevoplan (Sevoflurane 100\u002F250ml) and Isoplan (Isoflurane 100\u002F250ml). Its exports products include CIPROFLOXACIN INJECTION USP WITH DEXTROSE and FLUCONAZOLE INJECTION USP."
} ]
, "management" : [
{
"name" : "Manoharlal Lal Gupta",
"title" : "Executive Chairman of the Board, Managing Director"
}
,
{
"name" : "Anil Mittal",
"age" : "48",
"title" : "Chief Executive, Whole-time Director"
}
,
{
"name" : "Aradhana Kulkarni",
"title" : "Compliance Officer, Company Secretary"
}
,
{
"name" : "Vinod Kumar Gupta",
"age" : "65",
"title" : "Managing Director, Executive Director"
}
,
{
"name" : "Govind Das Garg",
"age" : "65",
"title" : "Whole-time Director"
}
,
{
"name" : "Shree Ganesh Chambers",
"title" : "Company Secretary"
}
,
{
"name" : "Balkrishna V. Chaubal",
"title" : "Nominee Director"
}
,
{
"name" : "Deepali Garhewal",
"title" : "Additional Independent Director"
}
,
{
"name" : "Sandeep Vyas",
"title" : "Additional Independent Director"
}
,
{
"name" : "Dharam Pal Khanna",
"title" : "Independent Non-Executive Director"
}
]
,"moreresources" : [
]
}]
